Jump to content

ATUM

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Doprendek (talk | contribs) at 02:02, 18 November 2016 (added Category:2003 establishments in California using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DNA2.0
Company typePrivate
IndustryBiotechnology
Founded2003
FoundersSridhar Govindarajan, Claes Gustafsson, Jeremy Minshull, Jon Ness
Headquarters
Newark, California
,
U.S.
ProductsGene Synthesis, Protein Engineering, Protein Production, Bioinformatics
Websitewww.DNA20.com

DNA2.0 provides products and services for life science and Synthetic biology research. DNA2.0 also provides free access to research tools such as Gene Designer, DNA Atlas and a gRNA designer.

The company

DNA2.0 was founded in 2003, in Menlo Park, California. The company is privately held[1] and continues to have all research, development and production in California, currently in their 50,000 sq ft Newark facility.[2] It began and continues as a gene synthesis and protein engineering provider to academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. Gene Synthesis rapidly replaced molecular cloning for many academic and corporate labs, as "foundries for the biotechnology age" allowing made-to-order genes for biological research.[3] DNA2.0 was featured on the PBS show Nova ScienceNow[4] to show how genes are created synthetically in a lab. In 2008, the company supplied some of the DNA stretches used to create a synthetic bacterial genome.[5] Dan Rather Reports included DNA2.0 in their episode on Synthetic Biology[6] and how it is solving "some of the most important problems facing the world."[6] In 2009, The Scientist named the codon design algorithms[7] (now trademarked as GeneGPS) developed by DNA2.0 as one of the Top 10 Innovations of the year for Life Sciences.[8] DNA2.0 developed the Electra Vector System, a universal cloning system that utilizes the type IIS restriction enzyme SapI and T4 DNA ligase in a single-tube reaction.[9] DNA2.0 has made some molecular components, such as synthetic fluorescent proteins, available in open-access collections of DNA parts (BioBricks Foundation).[10] DNA2.0 is a founding member of the International Gene Synthesis Consortium (IGSC) to promote biosecurity in the gene-synthesis industry.[11][12] There are over 1,200[13] published scientific articles using DNA2.0 products and/or services, of which 44[14] include company employees as an author(s).

Research Tools

Partnerships

  • The Perelman School of Medicine at the University of Pennsylvania will use the GeneGPS technology developed by DNA2.0 primarily to support the Gene Therapy Program’s work on HIV-1 vaccine development by optimizing in vivo protein expression.[20][21]
  • The Infection and Immunity Research Centre at St. George’s, University of London and DNA2.0 partnered to develop plant-based pharmaceuticals.[22]
  • Adimab LLC. and DNA2.0 employ an alliance in the area of antibody discovery and biomanufacturing via the design and construction of antibody libraries.
  • Cytovance Biologics utilizes GeneGPS from DNA2.0 as part of their Keystone Expression System for microbial strain development for successful biomanufacturing.
  • Archer Daniels Midland Company applies DNA2.0's proprietary protein engineering technology, ProteinGPS, to ADM’s industrial enzyme engineering processes.[23]
  • DNA2.0 is a sponsor of BioBuilder, a resource for hands-on activities and informative animations on synthetic biology for middle school and high school students and teachers; founded by Dr. Natalie Kuldell at MIT.

Patents

Fluorescent and colored proteins and methods for using them {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Methods, compositions and kits for a one-step DNA cloning system {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Methods, compositions and kits for one-step DNA cloning using DNA topoisomerase {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Fluorescent and colored proteins and methods for using them {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Design, synthesis and assembly of synthetic nucleic acids {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Systems and methods for biopolymer engineering {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Systems and methods for antibody engineering {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Systems and methods for constructing frequency lookup tables for expression systems {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Methods, compositions and kits for one-step DNA cloning using DNA topoisomerase {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Production of an .alpha.-carboxyl-.omega.-hydroxy fatty acid using a genetically modified Candida strain {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |inventor4-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Synthetic nucleic acids for expression of encoded proteins {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Systems and methods for biopolymer engineering {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Systems and methods for designing and ordering polynucleotides {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |inventor3-last= ignored (help); Unknown parameter |inventor4-last= ignored (help); Unknown parameter |inventor5-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Methods for determining properties that affect an expression property value of polynucleotides in an expression system {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

Synthetic nucleic acids for expression of encoded proteins {{citation}}: Unknown parameter |country-code= ignored (help); Unknown parameter |inventor-last= ignored (help); Unknown parameter |inventor2-last= ignored (help); Unknown parameter |issue-date= ignored (help); Unknown parameter |patent-number= ignored (help)

References

  1. ^ Duan, Mary (October 18, 2009). "Gene synthesis: It's no strain for DNA 2.0". Silicon Valley Business Journal. San Jose, CA.
  2. ^ "DNA2.0 Builds State of the Art Bioproduction Facility in Newark, California". MercuryNews.com. The San Jose Mercury News. Retrieved 22 March 2016.
  3. ^ Pollack (September 12, 2007). "How Do You Like Your Genes? Biofabs Take Orders". The New York Times. New York.
  4. ^ "Artificial Life". Nova ScienceNow. October 18, 2005. PBS.
  5. ^ Pollack (January 24, 2008). "Scientists Take New Step Toward Man-Made Life". The New York Times. New York.
  6. ^ a b "Cutting Edge". Dan Rather Reports. April 30, 2013. AXS TV.
  7. ^ Welch; Govindarajan; Ness; Villalobos; Gurney; Minshull; Gustafsson (September 14, 2009). "Design parameters to control synthetic gene expression in Escherichia coli". PLOS ONE. 4 (9): e7002. doi:10.1371/journal.pone.0007002. PMC 2736378. PMID 19759823.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  8. ^ "2009 Top 10 Innovations". The Scientist. 23 (12): 41–52. December 1, 2009.
  9. ^ Whitman; Gore; Ness; Theodorou; Minshull (June 2013), "Rapid, Scarless Cloning of Gene Fragments Using SapI, T4 DNA Ligase and the DNA2.0 Electra Vector System" (PDF), NEB Expressions, II: 8
  10. ^ Ledford, Heidi (July 4, 2013). "Bioengineers Look Beyond Patents". Nature. 499. Macmillan Publishers Limited: 16–17. doi:10.1038/499016a.
  11. ^ Hayden, Erika Check (November 18, 2009). "Gene-makers form security coalition". Nature. doi:10.1038/news.2009.1095.
  12. ^ "Gene-Synthesis Firms Set Up Biosecurity Protocol", Genetic Engineering & Biotechnology News, November 18, 2009
  13. ^ "Literature Database Search All". April 29, 2016.
  14. ^ "Literature Database Search Author Affiliation:DNA2.0". April 29, 2016.
  15. ^ Villalobos, Alan; Ness, Jon E; Gustafsson, Claes; Minshull, Jeremy; Govindarajan, Sridhar (2006). "Gene Designer: A synthetic biology tool for constructing artificial DNA segments". BMC Bioinformatics. 7: 285. doi:10.1186/1471-2105-7-285. PMC 1523223. PMID 16756672.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  16. ^ Villalobos, Alan; Welch, Mark; Minshull, Jeremy (2012). "In Silico Design of Functional DNA Constructs". Gene Synthesis. Methods in Molecular Biology. 852: 197–213. doi:10.1007/978-1-61779-564-0_15. ISBN 978-1-61779-563-3. PMID 22328435.
  17. ^ Welch, M; Villalobos, A; Gustafsson, C; Minshull, J (2011). "Designing genes for successful protein expression". Methods in enzymology. 498: 43–66. doi:10.1016/B978-0-12-385120-8.00003-6. PMID 21601673.
  18. ^ Dance, Amber (July 1, 2012). "Mover Over, Mother Nature". The Scientist.
  19. ^ "Best of the Web". Genetic Engineering News. April 15, 2007.
  20. ^ "Optimizing Gene Expression with DNA2.0 Technology". GEN. November 14, 2012.
  21. ^ McEnery, Regina (February 4, 2013), "Delivering the DNA", VAX The Bulletin on AIDS Vaccine Research, 11 (1)
  22. ^ Cohen, Bryan (December 24, 2013). "DNA2.0 Announces Biopharmaceutical Partnership with St. George's". Vaccine News.
  23. ^ "ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement". San Jose Mercury News. San Jose, CA. November 17, 2014.
Retrieved from "https://en.wikipedia.org/w/index.php?title=ATUM&oldid=750146251"